Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Coenzyme recalled?

Not under an active recall. Coenzyme was recalled 5 times in the past — all now closed. Most recent: Jan 15, 2020.

Most common reason: Sterility / contamination (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Coenzyme. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Coenzyme recalls on record

none so far in 2026; 5 on record, newest first
Class II · Moderate risk

CoEnzyme-Q10 injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1156-2018
Class II · Moderate risk

CoEnzymeQ10 25mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0637-2018
Class II · Moderate risk

Coenzyme Q-10

Labeling: Label Mixup; COENZYME Q-10 Capsule, 100 mg may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD30180_13, EXP: 5/9/2014; ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: AD33897_1, EXP: 5/9/2014; TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD37056_1, EXP: 5/10/2014; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 576640

Terminated Labeling / mix-up Aidapak Services, LLC D-549-2014
Class II · Moderate risk

Coenzyme Q-10

Labeling: Label Mixup; COENZYME Q-10, Capsule, 30 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W002819, EXP: 6/7/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-468-2014